Slide 1Intranasal Medications in Hospice A Novel method of pain, dyspnea, seizure and anxiety control. Slide 2 Disclosures Off Label Medications will be discussed (all the…

1.1 Corporate Presentation NASDAQ: NBS Delivering Individualized Medicine David J. Mazzo, PhD Chief Executive Officer May 2015 2. Forward-looking statements 2 This presentation…

1.1 skintouch As far back as 6,000 B.C., our ancestors realized that red grapes had at least one special property — namely, that they could be fermented into delicious…

1. Anaplastic astrocytoma 2. Pilocytic astrocytoma 3. Glioblastoma multiforme 4. Oligodendroglioma WHO 2 5. ependymoma 6. Protoplasmic astrocytoma 7. Gemistocytic astrocytoma…

1. Recent Advances In The Development Of Innovative Therapies. The Celgene Pipeline Jean Caraux, MD PhD BTG, Hong Kong - February 23th 2013 2. 2 Targeting Unmet Medical Needs…

1. Global and China Monoclonal AntibodyIndustry Report, 2014-2019Oct. 2014 2. METHODOLOGYBoth primary and secondary research methodologies were usedin preparing this study.…

1. - 106 – 7. Journal of Nuclear Medicine 45:1647-1652;2004 99m Tc-Interleukin 2 scintigraphy as a potential tool for evaluating tumor-infiltrating lymphocytes in melanoma…

1. Proleukin® (aldesleukin for injection) for High-Dose I.V. Bolus Administration Clinical Practice Guide Rusti Portillas, MSN, RN, Duke University- Doctor of Nursing Practice…

1. Corporate Presentation April 2014 NASDAQ: GALT www.galectintherapeutics.com © 2014 Galectin Therapeutics NASDAQ:GALT 2. Forward Looking Statements This presentation contains,…

1. Corporate Presentation April 2014 NASDAQ: GALT www.galectintherapeutics.com © 2014 Galectin Therapeutics NASDAQ:GALT 2. Forward Looking Statements This presentation contains,…